GOLDSTEIN ALLAN L reported 1 transaction at REGENERX BIOPHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 7/9/2018ACC: 0000914190-18-000280
Director
Since Jul 2018
0.00
Net shares
Net seller
$12.5K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
208.91K acquired · 208.91K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+208.91K
Price / share
$0.06
Trade value
$12.53K
% of position
16.2%
7/5/2018
1.29M→1.50M
Total
Net shares
+208.91K
Net value
$12.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/5/2018 | C · Conversion | +208.91K | $0.06 | $12.53K | 16.2% | 1.29M | 1.50M |
| Total | +208.91K | $12.53K | ||||||
Derivative Transactions1
Convertible Promissory Note (right to buy)
Direct
Converts to
Common Stock
208.91K shares
Shares
−208.91K
Strike price
.06
Held after
0.00
Exercisable
—
7/5/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Convertible Promissory Note (right to buy) Direct | Common Stock208.91K shares | 7/5/2018 | C · Conversion | −208.91K | .06 | — | 0.00 |